{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:20:47Z","timestamp":1788967247549,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Project of Chongqing Municipal Science and Technology Commission and Health Commission","award":["2026MSXM004"],"award-info":[{"award-number":["2026MSXM004"]}]},{"name":"Chongqing Natural Science Foundation Project","award":["CSTB2023NSCQ-MSX0222"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0222"]}]},{"name":"Scientific Research Project of Yongchuan Hospital Affiliated to Chongqing Medical University","award":["YJJL2024070"],"award-info":[{"award-number":["YJJL2024070"]}]},{"name":"Scientific Research Project of Yongchuan Hospital Affiliated to Chongqing Medical University","award":["YJJL2024073"],"award-info":[{"award-number":["YJJL2024073"]}]},{"name":"Chongqing public health key specialty (discipline) project","award":["Chongqing public health key specialty (discipline) project"],"award-info":[{"award-number":["Chongqing public health key specialty (discipline) project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08647-4","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:13:48Z","timestamp":1784290428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM24 stabilizes the p110 CUX1 oncoprotein via USP10 to promote chemoresistance in acute myeloid leukemia"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhi-Yin","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"8647_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM, Acute Myeloid L. 2025 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol. 2025;100:860\u201391.","journal-title":"Am J Hematol"},{"key":"8647_CR2","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401:2073\u201386.","journal-title":"Lancet"},{"key":"8647_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, Garcia-Manero G, Konopleva M, Ravandi F. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11:41.","journal-title":"Blood Cancer J"},{"key":"8647_CR4","first-page":"46","volume":"75","author":"HM Kantarjian","year":"2024","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, Jabbour E, Schiffer CA, Lang A, Ravandi F. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2024;75:46\u201367.","journal-title":"CA Cancer J Clin"},{"key":"8647_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366.","journal-title":"Haematologica"},{"key":"8647_CR6","doi-asserted-by":"publisher","first-page":"101286","DOI":"10.1016\/j.drup.2025.101286","volume":"83","author":"F Song","year":"2025","unstructured":"Song F, Lin S, Xu T, Yang C, Sharavyn B, Naranmandura H, Zhang Y, Huang P. Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy. Drug Resist Updat. 2025;83:101286.","journal-title":"Drug Resist Updat"},{"key":"8647_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.2019001982","volume":"136","author":"S DeWolf","year":"2020","unstructured":"DeWolf S, Tallman MS. How I treat relapsed or refractory AML. Blood. 2020;136:1023\u201332.","journal-title":"Blood"},{"key":"8647_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/ajh.25162","volume":"93","author":"C Ganzel","year":"2018","unstructured":"Ganzel C, Sun Z, Cripe LD, Fernandez HF, Douer D, Rowe JM, Paietta EM, Ketterling R, O\u2019Connell MJ, Wiernik PH, et al. Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience. Am J Hematol. 2018;93:1074\u201381.","journal-title":"Am J Hematol"},{"key":"8647_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41408-025-01418-2","volume":"15","author":"S Elias","year":"2025","unstructured":"Elias S, Brown S, Egini O, Walji M, Homsy S, Velayati A, Devlin S, Ponce DM, Kennedy V, Bharadwaj S, et al. Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort. Blood Cancer J. 2025;15:208.","journal-title":"Blood Cancer J"},{"key":"8647_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"8647_CR11","doi-asserted-by":"publisher","first-page":"eadx3827","DOI":"10.1126\/sciadv.adx3827","volume":"11","author":"Y-T Li","year":"2025","unstructured":"Li Y-T, Li K-Y, Tao S-S, Wang T, Lu Y, Chen H, Zhan Y-Q, Zhao K, Xiang S-S, Li J-J, et al. USP13 stabilizes NLRP3 to facilitate inflammasome activation by preventing TRIM31-mediated NLRP3 ubiquitination and degradation. Sci Adv. 2025;11:eadx3827.","journal-title":"Sci Adv"},{"key":"8647_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-025-07757-z","volume":"16","author":"X Du","year":"2025","unstructured":"Du X, Yu R, Yan C, Dong P, Wei C, Wang B, Zhang C, He Y, Wei Y, Han L, et al. USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. Cell Death Dis. 2025;16:449.","journal-title":"Cell Death Dis"},{"key":"8647_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41419-025-07922-4","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Wu Y, Guo J, Huang P, Li Q, Gao Z, Hu Y, Gao A, Sun M, Min H, et al. TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification. Cell Death Dis. 2025;16:621.","journal-title":"Cell Death Dis"},{"key":"8647_CR14","doi-asserted-by":"crossref","unstructured":"Park SS, Baek KH. Acute myeloid leukemia-related proteins modified by ubiquitin and ubiquitin-like proteins. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23010514"},{"key":"8647_CR15","doi-asserted-by":"publisher","first-page":"1304639","DOI":"10.3389\/fmolb.2023.1304639","volume":"10","author":"S Lv","year":"2023","unstructured":"Lv S, Zhang J, Peng X, Liu H, Liu Y, Wei F. Ubiquitin signaling in pancreatic ductal adenocarcinoma. Front Mol Biosci. 2023;10:1304639.","journal-title":"Front Mol Biosci"},{"key":"8647_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, Xin H. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11:75.","journal-title":"Exp Hematol Oncol"},{"key":"8647_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/sj.leu.2402452","volume":"16","author":"D Gandini","year":"2002","unstructured":"Gandini D, De Angeli C, Aguiari G, Manzati E, Lanza F, Pandolfi PP, Cuneo A, Castoldi GL, del Senno L. Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML. Leukemia. 2002;16:886\u201393.","journal-title":"Leukemia"},{"key":"8647_CR18","doi-asserted-by":"publisher","first-page":"e37657","DOI":"10.1371\/journal.pone.0037657","volume":"7","author":"H Li","year":"2012","unstructured":"Li H, Sun L, Tang Z, Fu L, Xu Y, Li Z, Luo W, Qiu X, Wang E. Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer. PLoS ONE. 2012;7:e37657.","journal-title":"PLoS ONE"},{"key":"8647_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.ajpath.2010.12.026","volume":"178","author":"M Chambon","year":"2011","unstructured":"Chambon M, Orsetti B, Berthe M-L, Bascoul-Mollevi C, Rodriguez C, Duong V, Gleizes M, Th\u00e9not S, Bibeau F, Theillet C, et al. Prognostic significance of TRIM24\/TIF-1\u03b1 gene expression in breast cancer. Am J Pathol. 2011;178:1461\u20139.","journal-title":"Am J Pathol"},{"key":"8647_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nature09542","volume":"468","author":"W-W Tsai","year":"2010","unstructured":"Tsai W-W, Wang Z, Yiu TT, Akdemir KC, Xia W, Winter S, Tsai C-Y, Shi X, Schwarzer D, Plunkett W, et al. TRIM24 links a non-canonical histone signature to breast cancer. Nature. 2010;468:927\u201332.","journal-title":"Nature"},{"key":"8647_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.yexcr.2018.04.006","volume":"367","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Zhao L, Shi K, Huang Z, Chen B. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Exp Cell Res. 2018;367:274\u201381.","journal-title":"Exp Cell Res"},{"key":"8647_CR22","doi-asserted-by":"publisher","first-page":"e85462","DOI":"10.1371\/journal.pone.0085462","volume":"9","author":"X Liu","year":"2014","unstructured":"Liu X, Huang Y, Yang D, Li X, Liang J, Lin L, Zhang M, Zhong K, Liang B, Li J. Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma. PLoS ONE. 2014;9:e85462.","journal-title":"PLoS ONE"},{"key":"8647_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccell.2016.04.012","volume":"29","author":"AC Groner","year":"2016","unstructured":"Groner AC, Cato L, de Tribolet-Hardy J, Bernasocchi T, Janouskova H, Melchers D, Houtman R, Cato ACB, Tschopp P, Gu L, et al. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell. 2016;29:846\u201358.","journal-title":"Cancer Cell"},{"key":"8647_CR24","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1002\/cam4.3310","volume":"9","author":"W Xie","year":"2020","unstructured":"Xie W, Zhang Y, Wang B, Hu Y, Zhan B, Wei F, Tang J, Lian J. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling. Cancer Med. 2020;9:6367\u201376.","journal-title":"Cancer Med"},{"key":"8647_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13578-024-01289-3","volume":"14","author":"Y Yao","year":"2024","unstructured":"Yao Y, Zhou S, Yan Y, Fu K, Xiao S. The tripartite motif-containing 24 is a multifunctional player in human cancer. Cell Biosci. 2024;14:103.","journal-title":"Cell Biosci"},{"key":"8647_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Yin J, Ji C, Yu X, Xue J, Guan X, Zhang S, Liu X, Xing F. Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. J Exp Clin Cancer Res. 2023;42:225.","journal-title":"J Exp Clin Cancer Res"},{"key":"8647_CR27","doi-asserted-by":"crossref","unstructured":"Tao L, Liu X, Jiang X, Zhang K, Wang Y, Li X, Jiang S, Han T. USP10 as a potential therapeutic target in human cancers. Genes (Basel). 2022;13.","DOI":"10.3390\/genes13050831"},{"key":"8647_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","volume":"140","author":"J Yuan","year":"2010","unstructured":"Yuan J, Luo K, Zhang L, Cheville JC, Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010;140:384\u201396.","journal-title":"Cell"},{"key":"8647_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/nchembio.2486","volume":"13","author":"EL Weisberg","year":"2017","unstructured":"Weisberg EL, Schauer NJ, Yang J, Lamberto I, Doherty L, Bhatt S, Nonami A, Meng C, Letai A, Wright R, et al. Inhibition of USP10 induces degradation of oncogenic FLT3. Nat Chem Biol. 2017;13:1207\u201315.","journal-title":"Nat Chem Biol"},{"key":"8647_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40364-021-00320-w","volume":"9","author":"H Lei","year":"2021","unstructured":"Lei H, Wang J, Hu J, Zhu Q, Wu Y. Deubiquitinases in hematological malignancies. Biomark Res. 2021;9:66.","journal-title":"Biomark Res"},{"key":"8647_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41401-020-0455-x","volume":"42","author":"M Yu","year":"2020","unstructured":"Yu M, Fang Z-X, Wang W-W, Zhang Y, Bu Z-L, Liu M, Xiao X-H, Zhang Z-L, Zhang X-M, Cao Y, et al. Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways. Acta Pharmacol Sin. 2020;42:604\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"8647_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fonc.2020.00738","volume":"10","author":"N Liu","year":"2020","unstructured":"Liu N, Sun Q, Wan L, Wang X, Feng Y, Luo J, Wu H. CUX1, A Controversial Player in Tumor Development. Front Oncol. 2020;10:738.","journal-title":"Front Oncol"},{"key":"8647_CR33","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/mc.23793","volume":"63","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhong L, Wang M, Wan P, Chu X, Chen S, Zhou Z, Shao X, Liu B. p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K\/AKT\/mTOR signaling pathway. Mol Carcinog. 2024;63:2063\u201377.","journal-title":"Mol Carcinog"},{"key":"8647_CR34","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1038\/sj.onc.1210398","volume":"26","author":"T Aleksic","year":"2007","unstructured":"Aleksic T, Bechtel M, Krndija D, von Wichert G, Knobel B, Giehl K, Gress TM, Michl P. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation. Oncogene. 2007;26:5939\u201349.","journal-title":"Oncogene"},{"key":"8647_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cellsig.2012.10.008","volume":"25","author":"K-c Liu","year":"2012","unstructured":"Liu K-c, Lin B-s, Zhao M, Wang K-y. Lan X-p. Cutl1: a potential target for cancer therapy. Cell Signal. 2012;25:349\u201354.","journal-title":"Cell Signal"},{"key":"8647_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19:146.","journal-title":"Mol Cancer"},{"key":"8647_CR37","doi-asserted-by":"publisher","first-page":"194979","DOI":"10.1016\/j.bbagrm.2023.194979","volume":"1866","author":"G Dagar","year":"2023","unstructured":"Dagar G, Kumar R, Yadav KK, Singh M, Pandita TK. Ubiquitination and deubiquitination: Implications on cancer therapy. Biochim Biophys Acta Gene Regul Mech. 2023;1866:194979.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"8647_CR38","doi-asserted-by":"crossref","unstructured":"Chen S, Lin J, Yang Z, Wang Y, Wang Q, Wang D, Qu Y, Lin Q, Liu J, Yan S, et al. TRIM24-mediated K27-linked ubiquitination of ULK1 alleviates energy stress-induced autophagy and promote prostate cancer growth in the context of SPOP mutation. Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01582-9"},{"key":"8647_CR39","doi-asserted-by":"crossref","unstructured":"Zhu Q, Yu T, Gan S, Wang Y, Pei Y, Zhao Q, Pei S, Hao S, Yuan J, Xu J, et al. TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination. J Exp Med. 2020;217.","DOI":"10.1084\/jem.20192083"},{"key":"8647_CR40","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1158\/0008-5472.CAN-23-3971","volume":"84","author":"D Liu","year":"2024","unstructured":"Liu D, Li M, Zhao Z, Zhou L, Zhi F, Guo Z, Cui J. Targeting the TRIM14\/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1. Cancer Res. 2024;84:2806\u201319.","journal-title":"Cancer Res"},{"key":"8647_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41419-025-07807-6","volume":"16","author":"X Yue","year":"2025","unstructured":"Yue X, Xiang Z, Yi Y, Wang X, Zhou W, Wu W, Qin W, Zhao Y, Bu X, Peng Z. Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC. Cell Death Dis. 2025;16:481.","journal-title":"Cell Death Dis"},{"key":"8647_CR42","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/MCB.00465-13","volume":"33","author":"MM-U Zaman","year":"2013","unstructured":"Zaman MM-U, Nomura T, Takagi T, Okamura T, Jin W, Shinagawa T, Tanaka Y, Ishii S. Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2013;33:4971\u201384.","journal-title":"Mol Cell Biol"},{"key":"8647_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-019-0092-z","volume":"5","author":"Y Liao","year":"2019","unstructured":"Liao Y, Liu N, Xia X, Guo Z, Li Y, Jiang L, Zhou R, Tang D, Huang H, Liu J. USP10 modulates the SKP2\/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia. Cell Discov. 2019;5:24.","journal-title":"Cell Discov"},{"key":"8647_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41416-020-0731-z","volume":"122","author":"J Yang","year":"2020","unstructured":"Yang J, Meng C, Weisberg E, Case A, Lamberto I, Magin RS, Adamia S, Wang J, Gray N, Liu S, et al. Inhibition of the deubiquitinase USP10 induces degradation of SYK. Br J Cancer. 2020;122:1175\u201384.","journal-title":"Br J Cancer"},{"key":"8647_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12032-024-02398-2","volume":"41","author":"M Wang","year":"2024","unstructured":"Wang M, Zhong L, Zhang H, Wan P, Chu X, Shao X, Chen S, Zhou Z, Yu L, Liu B. p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway. Med Oncol. 2024;41:166.","journal-title":"Med Oncol"},{"key":"8647_CR46","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.lfs.2019.117229","volume":"242","author":"L Yu","year":"2019","unstructured":"Yu L, Zhong L, Xiong L, Dan W, Li J, Ye J, Wan P, Luo X, Chu X, Liu C, et al. Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 CUX1 promotes cell proliferation and inhibits cell differentiation in APL. Life Sci. 2019;242:117229.","journal-title":"Life Sci"},{"key":"8647_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-021-00870-3","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, et al. Activation of RAS\/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther. 2022;7:51.","journal-title":"Signal Transduct Target Ther"},{"key":"8647_CR48","doi-asserted-by":"publisher","first-page":"103441","DOI":"10.1016\/j.ebiom.2021.103441","volume":"69","author":"Q Ling","year":"2021","unstructured":"Ling Q, Li F, Zhang X, Mao S, Lin X, Pan J, Ye W, Wei W, Qian Y, Hu C, et al. MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage\/repair system and MAPK pathway. EBioMedicine. 2021;69:103441.","journal-title":"EBioMedicine"},{"key":"8647_CR49","doi-asserted-by":"crossref","unstructured":"Fajardo-Ordu\u00f1a GR, Ledesma-Mart\u00ednez E, Agui\u00f1iga-S\u00e1nchez I, Mora-Garc\u00eda MdL, Weiss-Steider B, Santiago-Osorio E. Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22094955"},{"key":"8647_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-025-07653-6","volume":"16","author":"S Yeon Chae","year":"2025","unstructured":"Yeon Chae S, Jang S-Y, Kim J, Hwang S, Malani D, Kallioniemi O, Yun SG, Kim J-S, Kim HI. Mechanisms of chemotherapy failure in refractory\/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolism. Cell Death Dis. 2025;16:331.","journal-title":"Cell Death Dis"},{"key":"8647_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41589-018-0010-y","volume":"14","author":"LN Gechijian","year":"2018","unstructured":"Gechijian LN, Buckley DL, Lawlor MA, Reyes JM, Paulk J, Ott CJ, Winter GE, Erb MA, Scott TG, Xu M, et al. Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands. Nat Chem Biol. 2018;14:405\u201312.","journal-title":"Nat Chem Biol"},{"key":"8647_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41420-025-02355-6","volume":"11","author":"C Bouvier","year":"2025","unstructured":"Bouvier C, Gonzalez-Santamarta M, Profit\u00f3s-Pelej\u00e0 N, Armengol M, Quinet G, Alasseur Q, Ceccato L, Xolalpa W, Freire R, Guillermet-Guibert J, et al. Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma. Cell Death Discov. 2025;11:108.","journal-title":"Cell Death Discov"},{"key":"8647_CR53","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/s41401-023-01088-5","volume":"44","author":"J-H Huang","year":"2023","unstructured":"Huang J-H, Huang C-J, Yu L-N, Guan X-L, Liang S-W, Li J-H, Liang L, Wei M-Y, Zhang L-M. Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis. Acta Pharmacol Sin. 2023;44:1962\u201376.","journal-title":"Acta Pharmacol Sin"},{"key":"8647_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12967-021-03158-w","volume":"19","author":"M Han","year":"2021","unstructured":"Han M, Sun Y. Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma. J Transl Med. 2021;19:505.","journal-title":"J Transl Med"},{"key":"8647_CR55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12951-025-03656-9","volume":"23","author":"S Chen","year":"2025","unstructured":"Chen S, Chen E, Su J, Gong Y, Tang S, Qin A, Shen A, Tang S, Zhang L. Magnetically navigated nano-PROTAC ameliorates acute lung injury. J Nanobiotechnol. 2025;23:622.","journal-title":"J Nanobiotechnol"},{"key":"8647_CR56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/1348-0421.13231","volume":"69","author":"MI Jahan","year":"2025","unstructured":"Jahan MI, Inenaga T, Makimoto S, Hossain MB, Matsuoka Y, Sithi SN, Rajib SA, Ansori ANM, Sugata K, Imakawa K, et al. Circulating Cell-Free DNA of Bovine Leukemia Virus: A Promising Biomarker for Enzootic Bovine Leukosis. Microbiol Immunol. 2025;69:466\u201376.","journal-title":"Microbiol Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08647-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:45:07Z","timestamp":1788965107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08647-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8647"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08647-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of the Affiliated Yongchuan Hospital of Chongqing Medical University (Approval No. 2023-011), and all volunteers provided written informed consent.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors give full consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest exists.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1163"}}